J Rheum Dis.  2019 Oct;26(4):219-220. 10.4078/jrd.2019.26.4.219.

Longitudinal Changes of the European League Against Rheumatism Sjögren's Syndrome Patient Reported Index in Korean Patients with Primary Sjögren's Syndrome

• Kwok SK

• KMID: 2459446
• DOI: http://doi.org/10.4078/jrd.2019.26.4.219

Abstract

No abstract available.

MeSH Terms

Humans
Rheumatic Diseases*

Reference

1. Rischmueller M, Tieu J, Lester S. Primary Sjögren's syndrome. Best Pract Res Clin Rheumatol. 2016; 30:189–220.

2. Patel R, Shahane A. The epidemiology of Sjögren's syndrome. Clin Epidemiol. 2014; 6:247–255.

3. Mengshoel AM, Norheim KB, Omdal R. Primary Sjögren's syndrome: fatigue is an ever-present, fluctuating, and uncontrollable lack of energy. Arthritis Care Res (Hoboken). 2014; 66:1227–1232.

4. Lee J, Koh JH, Kwok SK, Park SH. The EULAR Sjögren's syndrome patient-reported index is an independent determinant of health-related utility values of Korean patients with primary Sjögren's syndrome. Clin Exp Rheumatol. 2016; 34:663–667.

5. Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, et al. EULAR Sjögren's Task Force. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis. 2010; 69:1103–1109.

6. Bowman SJ, Booth DA, Platts RG. UK Sjögren's Interest Group. Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool. Rheumatology (Oxford). 2004; 43:758–764.

7. Bowman SJ, Booth DA, Platts RG, Field A, Rostron J. UK Sjögren's Interest Group. Validation of the Sicca symptoms inventory for clinical studies of Sjögren's syndrome. J Rheumatol. 2003; 30:1259–1266.

8. Vitali C, Palombi G, Baldini C, Benucci M, Bombardieri S, Covelli M, et al. Sjögren's syndrome disease damage index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum. 2007; 56:2223–2231.

9. Bowman SJ, Sutcliffe N, Isenberg DA, Goldblatt F, Adler M, Price E, et al. Sjögren's systemic clinical activity index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome. Rheumatology (Oxford). 2007; 46:1845–1851.

10. Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, et al. EULAR Sjögren's Task Force. EULAR Sjogren's syndrome patient reported index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Ann Rheum Dis. 2011; 70:968–972.

11. Seror R, Theander E, Brun JG, Ramos-Casals M, Valim V, Dörner T, et al. EULAR Sjögren's Task Force. Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis. 2015; 74:859–866.

12. Kim JH, Ha YJ, Kang EH, Song YW, Lee YJ. Longitudinal changes in the European league against rheumatism Sjögren's syndrome patient reported index in real-life practice. J Rheum Dis. 2019; 26:191–199.

13. Lendrem D, Mitchell S, McMeekin P, Gompels L, Hackett K, Bowman S, et al. UK primary Sjögren's Syndrome Registry. Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome? Rheumatology (Oxford). 2015; 54:655–659.